The ATLANTIC study, involving several centers in Portugal and Spain, is the first study evaluating the safety and efficacy of intravitreal injections (namely aflibercept) as a treatment for polypoidal choroidal vasculopathy (PCV) in a Caucasian population. Rufino Silva, MD, PhD, principal investigator, briefly presents the study.
Perspective: Rufino Silva, MD, PhD
Other Perspective
Treat and Extend – Practical guide
Treat and Extend (T&E) has gained wide popularity as a proactive, pragmatic, individualized regi
Biosimilars, a new frontier?
Biosimilars entering the scene of intravitreal injections
Anti-VEGF therapies for AMD: where are we now?
Where are we now with the spread of these therapies for AMD to prevent blindness?
Defining Nonadherence and Nonpersistence to Anti-VEGF Therapies in nAMD
The nAMD Barometer Leadership Coalition published a definition for nonadherence and nonpersistence
Related Articles
